fda tirzepatide obesity Approves Zepbound for Sleep Apnea Patients With Lilly announces more next-gen obesity

But there are other ways the drug improves liver health outside of shedding pounds

Both medications lower blood glucose through different mechanisms, creating complementary effects

The move comes after the FDA took tirzepatide, the key ingredient in Eli Lilly's (LLY) diabetes drug Mounjaro and weight-loss drug Zepbound, off its shortage list

BMI 24.5 or higher: Eligible if you also have a weight-related health condition

Clinical trials have demonstrated that daily supplementation with L

The profound exhaustion, the racing heart upon standing, and the thick, suffocating "brain fog" are hallmarks of complex chronic conditions like Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and dysautonomia